Pharmaleads

Pharmaleads Designs and Develops Innovative Non-Opioid Drugs for Treating Acute and Chronic Severe Pain, a Growing Market with Significant Medical NeedsPharmaleads is developing drugs - Dual ENKephalinase Inhibitors (DENKIs) - based on our deep understanding of enkephalins, which are key elements in the physiological pain modulation system. DENKIs increase local concentrations of enkephalins by protecting them from degradation by enzymes, thereby inducing greater physiological analgesic effects and locally improving pain management.